Lior Susan serves as Executive at Lucira Health, Inc., where they oversee executive responsibilities. Since joining the company, Lior Susan has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 10, 2025 involved receiving (via award) 3,898,906 shares valued at $0.
Lior Susan currently holds 5,665,669 shares of Lucira Health, Inc. (LHDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lior Susan has been a net neutral trader of LHDX stock. They have purchased $0 and sold $0 worth of shares.
Lior Susan's most recent insider trade was on Oct 10, 2025, when they sold 3,898,906 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 15, 2021 | OWLT | $0 | Award | 14,930,616 | $N/A | Discretionary |
| Jul 15, 2021 | OWLT | $0 | Award | 13,561,716 | $N/A | Discretionary |
| Feb 9, 2021 | LHDX | $0 | Conversion | 976,852 | $N/A | Discretionary |
| Feb 9, 2021 | LHDX | $0 | Conversion | 877,445 | $N/A | Discretionary |
| Feb 9, 2021 | LHDX | $0 | Conversion | 185,512 | $N/A | Discretionary |
| Feb 9, 2021 | LHDX | $6.4M | Conversion | 473,729 | $13.60 | Discretionary |
| Feb 9, 2021 | LHDX | $0 | Conversion | 3,710,257 | $N/A | Discretionary |